Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -1,078.98%-52.78M | ---- | -138.81%-4.48M | ---- | 137.95%11.54M | ---- | 58.17%-30.4M | ---- | -374.12%-72.67M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 24.44%-34K | ---- | -125.00%-45K | ---- | -25.00%-20K | ---- | 97.99%-16K | ---- | -52.88%-795K |
| Impairment and provisions: | ---- | 130.77%20.48M | ---- | 904.44%8.87M | ---- | -118.26%-1.1M | ---- | -49.72%6.04M | ---- | 2,402.92%12.01M |
| -Impairment of trade receivables (reversal) | ---- | 96.07%18.4M | ---- | 671.85%9.38M | ---- | -1,943.82%-1.64M | ---- | -97.98%89K | ---- | 820.00%4.42M |
| -Other impairments and provisions | ---- | 506.46%2.08M | ---- | -194.98%-511K | ---- | -90.96%538K | ---- | -21.66%5.95M | ---- | --7.6M |
| Revaluation surplus: | ---- | 126.87%223K | ---- | ---830K | ---- | ---- | ---- | ---- | ---- | 3,397.31%55.13M |
| -Other fair value changes | ---- | 126.87%223K | ---- | ---830K | ---- | ---- | ---- | ---- | ---- | 3,397.31%55.13M |
| Asset sale loss (gain): | ---- | ---- | ---- | -147.38%-1.74M | ---- | 443.71%3.66M | ---- | ---1.07M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---1.74M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | 443.71%3.66M | ---- | ---1.07M | ---- | ---- |
| Depreciation and amortization: | ---- | 5.17%44.89M | ---- | 11.31%42.68M | ---- | 1.44%38.34M | ---- | 14.51%37.8M | ---- | 9.07%33.01M |
| -Depreciation | ---- | 5.17%44.89M | ---- | 11.31%42.68M | ---- | 1.44%38.34M | ---- | 14.51%37.8M | ---- | 9.07%33.01M |
| Financial expense | ---- | -4.99%23.96M | ---- | 4.20%25.22M | ---- | -17.14%24.2M | ---- | 4.94%29.2M | ---- | 12.95%27.83M |
| Exchange Loss (gain) | ---- | ---- | ---- | 16.03%-110K | ---- | 6.43%-131K | ---- | 65.69%-140K | ---- | -1,300.00%-408K |
| Special items | ---- | -62.64%-8.93M | ---- | 63.07%-5.49M | ---- | -173.50%-14.87M | ---- | 627.67%20.24M | ---- | -2.38%-3.84M |
| Operating profit before the change of operating capital | ---- | -56.62%27.8M | ---- | 4.00%64.08M | ---- | -0.07%61.62M | ---- | 22.65%61.66M | ---- | -33.84%50.27M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 72.01%-13.57M | ---- | -85.86%-48.47M | ---- | -456.63%-26.08M | ---- | 68.28%-4.69M | ---- | -180.54%-14.77M |
| Accounts receivable (increase)decrease | ---- | -353.60%-24.5M | ---- | 151.65%9.66M | ---- | 139.78%3.84M | ---- | -259.05%-9.65M | ---- | 116.11%6.07M |
| Accounts payable increase (decrease) | ---- | 196.27%11.34M | ---- | -127.57%-11.78M | ---- | 141.53%42.72M | ---- | 68.72%17.69M | ---- | 221.64%10.48M |
| prepayments (increase)decrease | ---- | 99.22%-454K | ---- | -711.49%-58.5M | ---- | -27.80%-7.21M | ---- | 35.53%-5.64M | ---- | -5,852.38%-8.75M |
| Cash from business operations | ---- | 101.37%615K | ---- | -160.10%-45.01M | ---- | 26.14%74.89M | ---- | 37.10%59.37M | ---- | -9.57%43.31M |
| Special items of business | -278.92%-6.99M | 58.80%-192K | 106.60%3.91M | 18.67%-466K | -265.28%-59.2M | 66.25%-573K | 1,133.14%35.82M | 5.09%-1.7M | 69.62%-3.47M | -588.08%-1.79M |
| Net cash from operations | -278.92%-6.99M | 100.93%423K | 106.60%3.91M | -161.19%-45.47M | -265.28%-59.2M | 28.86%74.32M | 1,133.14%35.82M | 38.92%57.67M | 69.62%-3.47M | -12.83%41.52M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -24.44%34K | ---- | 125.00%45K | ---- | 25.00%20K | ---- | -36.00%16K | ---- | -95.19%25K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%7M | ---- | ---7M |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | -6,479.37%-8.29M | ---- | -102.52%-126K | ---- | 360.83%5M |
| Purchase of fixed assets | ---- | -355.43%-17.44M | ---- | 91.05%-3.83M | ---- | 51.16%-42.8M | ---- | -115.68%-87.63M | ---- | -895.88%-40.63M |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | -74.37%2.02M | ---- | --7.88M | ---- | ---- |
| Other items in the investment business | -31.37%3.88M | -39.87%9.35M | -32.36%5.65M | 443.97%15.55M | 129.60%8.35M | --2.86M | -34.68%-28.23M | ---- | -131.12%-20.96M | 31.71%1.41M |
| Net cash from investment operations | -31.37%3.88M | -168.48%-8.06M | -32.36%5.65M | 125.48%11.77M | 129.60%8.35M | 36.61%-46.19M | -34.68%-28.23M | -76.86%-72.86M | -131.12%-20.96M | -2,830.23%-41.2M |
| Net cash before financing | -132.59%-3.12M | 77.35%-7.64M | 118.80%9.56M | -219.82%-33.71M | -769.76%-50.85M | 285.20%28.13M | 131.08%7.59M | -4,876.42%-15.19M | -19.26%-24.43M | -99.31%318K |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -24.02%176.18M | ---- | 42.38%231.88M | ---- | -19.48%162.86M | ---- | 17.41%202.28M | ---- | -45.19%172.28M |
| Refund | ---- | -4.58%-165.75M | ---- | 14.44%-158.49M | ---- | -15.26%-185.23M | ---- | 20.91%-160.7M | ---- | 26.53%-203.18M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | -86.86%1.97M | ---- | --15M | ---- | ---- |
| Interest paid - financing | ---- | 38.68%-15.37M | ---- | -63.08%-25.06M | ---- | 44.60%-15.37M | ---- | -47.61%-27.74M | ---- | 4.43%-18.79M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---4M | ---- | ---- | ---- | ---- | ---- | ---10M |
| Pledged bank deposit (increase) decrease | ---- | --22K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | 50.57%-8.6M | 224.28%12.12M | -123.99%-17.4M | -0.15%-9.75M | 736.36%72.5M | 48.27%-9.73M | 144.17%8.67M | -395.46%-18.82M | 13.27%-19.63M | --6.37M |
| Net cash from financing operations | 50.57%-8.6M | -79.09%7.21M | -123.99%-17.4M | 175.20%34.48M | 736.36%72.5M | -577.07%-45.85M | 144.17%8.67M | 117.86%9.61M | 13.27%-19.63M | -407.52%-53.8M |
| Effect of rate | -39.74%3.85M | -76.56%1.05M | 139.90%6.38M | -49.18%4.49M | -31.61%-15.99M | 1,838.39%8.83M | -174.27%-12.15M | -138.75%-508K | 74.57%-4.43M | 665.09%1.31M |
| Other items affecting net cash | ---- | ---- | ---- | ---- | 95.00%-10K | ---- | -100.52%-200K | ---- | --38.46M | ---- |
| Net Cash | -49.51%-11.71M | -155.11%-426K | -136.21%-7.84M | 104.36%773K | 34.73%21.64M | -217.69%-17.72M | 386.99%16.06M | 89.57%-5.58M | 87.02%-5.6M | -183.94%-53.48M |
| Begining period cash | 8.02%8.43M | 207.04%7.8M | 207.04%7.8M | -77.77%2.54M | -77.77%2.54M | -34.74%11.43M | -34.74%11.43M | -74.86%17.52M | -74.86%17.52M | 1,023.29%69.69M |
| Items Period | ---- | ---- | ---- | ---- | ---- | ---- | --200K | ---- | ---- | ---- |
| Cash at the end | -91.18%560K | 8.02%8.43M | -22.43%6.35M | 207.04%7.8M | -47.32%8.19M | -77.77%2.54M | 107.45%15.54M | -34.74%11.43M | -18.22%7.49M | -74.86%17.52M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Chen Ho Yin Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.